Field PULSE

About Field Medical

Field Medical is an early-stage innovator in the rapidly growing pulsed field ablation (PFA) market for cardiac arrhythmias. The company is developing the FieldForce Ablation System and is actively conducting first-in-human clinical trials for both atrial fibrillation (AF) and ventricular tachycardia (VT). Led by CEO Dr. Mark Turco and founded by Dr. Steven Mickelsen, the company combines clinical expertise with engineering to create a potentially safer and more effective ablation technology. Field Medical is currently pre-revenue and is selectively engaging with strategic partners and investors to fund its development and clinical programs.

Therapeutic Areas